Cargando…

Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy

Clinical response predictions through image examinations after neoadjuvant chemotherapy (NAC) for breast cancer is important. The present study aimed to evaluate the utility of a novel imaging modality, positron-emission tomography/magnetic resonance imaging (PET/MRI), in predicting the pathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekine, Chikako, Uchiyama, Nachiko, Watase, Chikashi, Murata, Takeshi, Shiino, Sho, Jimbo, Kenjiro, Iwamoto, Eriko, Takayama, Shin, Kurihara, Hiroaki, Satomi, Kaishi, Yoshida, Masayuki, Kinoshita, Takayuki, Suto, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764658/ https://www.ncbi.nlm.nih.gov/pubmed/35070299 http://dx.doi.org/10.3892/mco.2021.2483

Ejemplares similares

Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report
por: Shiino, Sho, et al.
Publicado: (2020)

Spontaneous regression of occult breast cancer with axillary lymph node metastasis: A case report
por: Takayama, Shin, et al.
Publicado: (2019)

A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023)

Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study
por: Murata, Takeshi, et al.
Publicado: (2022)

Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
por: Shikata, Shohei, et al.
Publicado: (2023)

Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023)

Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives
por: Watase, Chikashi, et al.
Publicado: (2021)

A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report
por: Kurita, Arisa, et al.
Publicado: (2022)

Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services
por: Takayama, Shin, et al.
Publicado: (2023)

Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer
por: Shiino, Sho, et al.
Publicado: (2023)

Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography
por: Murakami, Ryusuke, et al.
Publicado: (2021)

Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer
por: Yazaki, Shu, et al.
Publicado: (2022)

Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis
por: Shiino, Sho, et al.
Publicado: (2021)

Cardiorespiratory fitness in breast cancer survivors: a randomised controlled trial of home-based smartphone supported high intensity interval training
por: Ochi, Eisuke, et al.
Publicado: (2022)

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017)

Novel combination of serum microRNA for detecting breast cancer in the early stage
por: Shimomura, Akihiko, et al.
Publicado: (2016)

Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
por: Yazaki, Shu, et al.
Publicado: (2022)

A tissue microRNA signature that predicts the prognosis of breast cancer in young women
por: Hironaka-Mitsuhashi, Ai, et al.
Publicado: (2017)

Comparative analysis between synthetic mammography reconstructed from digital breast tomosynthesis and full-field digital mammography for breast cancer detection and visibility
por: Murakami, Ryusuke, et al.
Publicado: (2020)

ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma
por: Murata, Yoshihiko, et al.
Publicado: (2014)

Role of fluorodeoxyglucose-positron emission tomography in predicting the pathological response and prognosis after neoadjuvant chemoradiotherapy for locally advanced non-small-cell lung cancer
por: Tanahashi, Masayuki, et al.
Publicado: (2022)

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
por: Kataoka, Akemi, et al.
Publicado: (2016)

Association of the Serum Endostatin Level, Renal Function, and Carotid Atherosclerosis of Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS)
por: Kato, Yoshifumi, et al.
Publicado: (2018)

Towards Circulating-Tumor DNA-Based Precision Medicine
por: Hironaka-Mitsuhashi, Ai, et al.
Publicado: (2019)

A rare case of brain metastasis from poorly differentiated small bowel adenocarcinoma
por: Yamazawa, Erika, et al.
Publicado: (2019)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement
por: Shinkai, Toko, et al.
Publicado: (2015)

EPEN-34. THE CRISPR-Cas9 SYSTEM-MEDIATED ENDOGENOUS GENE REARRANGEMENT INDUCED C11orf95-RELA FUSION IN VITRO AND IN VIVO THAT LED TO THE DEVELOPMENT OF EPENDYMOMA-LIKE TUMOR
por: Takadera, Mutsumi, et al.
Publicado: (2020)

Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report
por: Shibayama, Takahiro, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy and Appleby Procedure for Pancreatic Acinar Cell Carcinoma: A Case Report
por: Jimbo, Masaya, et al.
Publicado: (2016)

Stratifin accelerates progression of lung adenocarcinoma at an early stage
por: Shiba-Ishii, Aya, et al.
Publicado: (2015)

Breast Cancer Treatment in a Patient with Decubitus Ulcer Infection Secondary to Spina Bifida: Surgical Resection versus Neoadjuvant Chemotherapy
por: Sato, Fumiya, et al.
Publicado: (2021)

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2021)

Optimal Timing of Cataract Surgery and Panretinal Photocoagulation for Diabetic Retinopathy
por: Suto, Chikako, et al.
Publicado: (2011)

Choroidal Detachment after Uncomplicated Small Incision Cataract Surgery
por: Suto, Chikako, et al.
Publicado: (2012)

Iris rubeosis and hyphema caused by chemical injury due to household detergent
por: Suto, Chikako, et al.
Publicado: (2012)

Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma
por: Fujiwara, Susumu, et al.
Publicado: (2019)

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast
por: Yoshida, Masayuki, et al.
Publicado: (2015)

Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry
por: Kawai, Masaaki, et al.
Publicado: (2016)

Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma?
por: Kim, Hyung Sun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p0b75vjioalbbs22dv0s7cpckv